Mark Stringer

d-Morphine, but not l-morphine, has low micromolar affinity for the non-competitive N-methyl-d-aspartate site in rat forebrain. Possible clinical implications for the management of neuropathic pain

Mark Stringer, Matthew Makin, John Miles et al. · Neuroscience Letters · 2000 · 39 citations

Molecular Pharmacology, Health Sciences, Neuroanatomy +14

Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts

Michael Finigan, Tamara Perkins, Phyllis Zold-Kilbourn et al. · Journal of Substance Abuse Treatment · 2011 · 30 citations

Extended-release Naltrexone, Opioid Epidemic, Substance Abuse +10

Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers

Paul Crits‐Christoph, Christie Lundy, Mark Stringer et al. · Journal of Substance Abuse Treatment · 2015 · 19 citations · Full text

Extended-release Naltrexone, Opioid Epidemic, Substance Abuse +15

State targeted response to the opioid Crisis grants (opioid STR) program: Preliminary findings from two case studies and the national cross-site evaluation

Patrick M. High, Katherine R. Marks, Vestena Robbins et al. · Journal of Substance Abuse Treatment · 2019 · 19 citations

Opioid Epidemic, Public Policy, Substance Abuse +15

A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri

Paul Crits‐Christoph, Hannah M. Markell, Mary Beth Connolly Gibbons et al. · Journal of Substance Abuse Treatment · 2016 · 14 citations

Extended-release Naltrexone, Naturalistic Evaluation, Drug Monitoring +7